|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-9-9
|
|
pubmed:abstractText |
Insulin-like growth factor-1 (IGF-1) promotes the survival of neurons, mediates neuritic growth, and in 1 clinical trial human recombinant IGF-1 delayed the progression of functional impairment and decline of health-related quality of life in patients with amyotrophic lateral sclerosis (ALS).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1074-7931
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
315-8
|
|
pubmed:meshHeading |
pubmed-meshheading:20827122-Acromegaly,
pubmed-meshheading:20827122-Aged,
pubmed-meshheading:20827122-Amyotrophic Lateral Sclerosis,
pubmed-meshheading:20827122-Antineoplastic Agents, Hormonal,
pubmed-meshheading:20827122-Disease Progression,
pubmed-meshheading:20827122-Fatal Outcome,
pubmed-meshheading:20827122-Female,
pubmed-meshheading:20827122-Growth Hormone-Secreting Pituitary Adenoma,
pubmed-meshheading:20827122-Human Growth Hormone,
pubmed-meshheading:20827122-Humans,
pubmed-meshheading:20827122-Insulin-Like Growth Factor I,
pubmed-meshheading:20827122-Octreotide,
pubmed-meshheading:20827122-Pituitary Neoplasms
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Rapid progression of amyotrophic lateral sclerosis in an acromegalic patient after surgical resection of a growth hormone-producing pituitary adenoma.
|
|
pubmed:affiliation |
Second Department of Medicine, Semmelweis University, Budapest, Hungary.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
